Cargando…
Gene expression information improves reliability of receptor status in breast cancer patients
Immunohistochemical (IHC) determination of receptor status in breast cancer patients is frequently inaccurate. Since it directs the choice of systemic therapy, it is essential to increase its reliability. We increase the validity of IHC receptor expression by additionally considering gene expression...
Autores principales: | Kenn, Michael, Schlangen, Karin, Castillo-Tong, Dan Cacsire, Singer, Christian F., Cibena, Michael, Koelbl, Heinz, Schreiner, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652334/ https://www.ncbi.nlm.nih.gov/pubmed/29100391 http://dx.doi.org/10.18632/oncotarget.20474 |
Ejemplares similares
-
Co-expressed genes enhance precision of receptor status identification in breast cancer patients
por: Kenn, Michael, et al.
Publicado: (2018) -
Decision theory for precision therapy of breast cancer
por: Kenn, Michael, et al.
Publicado: (2021) -
Microarray Normalization Revisited for Reproducible Breast Cancer Biomarkers
por: Kenn, Michael, et al.
Publicado: (2020) -
Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer
por: Kenn, Michael, et al.
Publicado: (2022) -
Molecular dynamics identifies semi-rigid domains in the PD-1 checkpoint receptor bound to its natural ligand PD-L1
por: Kenn, Michael, et al.
Publicado: (2022)